Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...

Download the detailed syllabus PDF here. Check the section-wise topics, exam pattern, preparation strategy, and best books.

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug ...

Pharmaceuticals announced a streamlined strategic focus on advancing and realizing the potential of apraglutide for the ...

As the clock ticks down, aspiring candidates for the National Defence Academy (NDA) are reminded that the registration window for the UPSC NDA 1 exam will close tomorrow, December 31. Interested ...

"We are pleased the FDA has accepted our NDA for Bumetanide Nasal Spray," said Benjamin Esque, CEO of Corstasis Therapeutics ...

Arrowhead Pharmaceuticals announces FDA acceptance of NDA for plozasiran to treat familial chylomicronemia syndrome, with a target action date of Nov.

A significant amendment proposed by the committee is that the existing Waqf properties cannot be questioned on the grounds of ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...

The article below provides detailed information about the NDA and CDS online application process, which includes application fees and other important information. Candidates who want to join the ...

State Auditor Diana DiZoglio on Tuesday charged that Massachusetts is relying on a “broken system” for both executing and ...